Parkwalk growth technology EIS Funds
Parkwalk Funds seek capital appreciation with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme (EIS) and Business Investment Relief (BIR).
Each Parkwalk Fund invests in a minimum of five companies, and investee companies range from early stage through to AIM-listed, creating a diverse portfolio of sectors and business development stages, with capital raised used for development, commercialisation and expansion through to acquisition capital.
Parkwalk manages a series of EIS Funds, including the University of Cambridge Enterprise Funds and the University of Oxford Isis Funds, allowing our investors access to some of the world’s highest calibre discoveries and IP.
All of Parkwalk’s fully-invested Funds are currently valued at a premium to original investment cost.
The Parkwalk Technology Funds seek to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK R&D intensive institutions and Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.
Parkwalk’s current portfolio
consists of over 27 companies, which have raised in excess of £250m of funding between them since 2010 and over 600 patents protect their technology and processes.
- sector diversification of investee companies
- investments range from early stage through to AIM-listed
- positive reviews by Allenbridge TSR and Churchill TER
- click here to email the funds team to request further information
Launched in conjunction with Cambridge Enterprise
, the University’s Technology Transfer subsidiary responsible for commercialisation arrangements for University discoveries, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in the development of scientific and technological discoveries made at the University of Cambridge in a tax efficient manner.
- Cambridge Fund II Closed in May 2013
- we expect to open Fund III in H2 2014
- click here to email the funds team to be notified when Fund III opens
Launched in conjunction with Isis Innovation
, the University’s Technology Transfer and academic consulting subsidiary, the University of Oxford Isis Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University of Oxford in a tax efficient manner.
- Oxford Fund I launched and closed Q1 2014
- we expect to launch Fund II in Q4 2014
- click here to email the funds team to be notified when Fund II opens
Investing since 2010, Parkwalk have had three portfolio companies list on AIM (the Alternative Investment Market of the London Stock Exchange) and in total seven (as of Q1 2014) are AIM- listed.
As at the end of Q1 2014, three of our 27 portfolio companies had successfully listed their shares on the Alternative Investment Market of the London Stock Exchange (AIM) – Revolymer, Horizon Discovery and Xeros. In total seven of our portfolio companies are now exchange-listed.
- Parkwalk invested in Xeros in October 2010, at 33.0p per share equivalent (26.4p net of initial tax relief), and the IPO price of 123p represented a 4.65x tax-free uplift for our investors in a little over three years.
- Parkwalk invested in Revolymer in April 2011, and the company successfully raised £25m when it listed on AIM in July 2012 at a small uplift to our original investment level.
- Parkwalk invested in Horizon Discovery in May 2013. The company had a hugely successful IPO in March 2014, raising £40m to list with a market capitalistion of £120m. The floatation was priced at over 100% above the price at which Parkwalk invested.
- Parkwalk invested in Tracsis plc in May 2011 at 45p per share (31.5p net of tax reliefs). As of April 2014 Tracsis shares were trading at 315p, representing a 10x tax-free uplift in just under three years.
Parkwalk Recent Investments
Parkwalk Funds seek capital appreciation to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.